Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals, Inc. company information, Employees & Contact Information

Updated June 2026

Quick answer

Achillion Pharmaceuticals, Inc. is a Pharmaceutical Manufacturing company. It has approximately 42 employees on record. Contact data was last refreshed in June 2026. Find Achillion Pharmaceuticals, Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

On January 28, 2020, Achillion Pharmaceuticals was acquired by Alexion Pharmaceuticals, Inc. As part of Alexion, we are continuing to advance a clinical-stage portfolio of orally administered factor D inhibitors and working toward the mission of transforming the lives of people with rare diseases.”

Company Details

Employees
42
Address
1777 Sentry Pkwy W, Blue Bell,pennsylvania 19422,united States
Phone
+215-709-3040
Email
in****@****ion.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Blue Bell, Pennsylvania
Looking for a particular Achillion Pharmaceuticals, Inc. employee's phone or email?

Achillion Pharmaceuticals, Inc. Questions

News

Judge rejects bid for 311 info in Achillion explosion lawsuit - Prince George Citizen

Judge rejects bid for 311 info in Achillion explosion lawsuit Prince George Citizen

Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors - NBC News

Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors NBC News

Achillion’s ACH-5228 Achieves Positive Results In Phase 1 Multiple Ascending Dose Study In Healthy Volunteers - BioSpace

Achillion’s ACH-5228 Achieves Positive Results In Phase 1 Multiple Ascending Dose Study In Healthy Volunteers BioSpace

Alexion to shell out $930m to acquire Achillion Pharmaceuticals - Pharmaceutical Technology

Alexion to shell out $930m to acquire Achillion Pharmaceuticals Pharmaceutical Technology

Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra - BioProcess International

Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra BioProcess International

Alexion acquiring Achillion to expand reach into rare, immune-related disease - statnews.com

Alexion acquiring Achillion to expand reach into rare, immune-related disease statnews.com

Alexion buys Achillion - Yale Daily News

Alexion buys Achillion Yale Daily News

Deshpande leaves Achillion after overseeing R&D pivot, freeing CEO chair for Truitt - Fierce Biotech

Deshpande leaves Achillion after overseeing R&D pivot, freeing CEO chair for Truitt Fierce Biotech

Alexion to Acquire Achillion in $930M Deal - Contract Pharma

Alexion to Acquire Achillion in $930M Deal Contract Pharma

INSIGHT: Alexion to Acquire Achillion With Contingent Value Rights - news.bloombergtax.com

INSIGHT: Alexion to Acquire Achillion With Contingent Value Rights news.bloombergtax.com

Boston firm acquires Achillion for $930 million, plus extra if drugs advance - Inquirer.com

Boston firm acquires Achillion for $930 million, plus extra if drugs advance Inquirer.com

The A-Team: Alexion to acquire Achillion in $930M deal - Hartford Business Journal

The A-Team: Alexion to acquire Achillion in $930M deal Hartford Business Journal

Janssen, Achillion Launch $1.1B+ Hepatitis Collaboration - Genetic Engineering and Biotechnology News

Janssen, Achillion Launch $1.1B+ Hepatitis Collaboration Genetic Engineering and Biotechnology News

Rare diseases: Alexion to acquire Achillion for $930m - Pharmaceutical Technology

Rare diseases: Alexion to acquire Achillion for $930m Pharmaceutical Technology

Johnson & Johnson pulls plug on Medivir-Achillion hep C cocktail to focus on hep B - Fierce Biotech

Johnson & Johnson pulls plug on Medivir-Achillion hep C cocktail to focus on hep B Fierce Biotech

Achillion names new CEO as top leader exits - Hartford Business Journal

Achillion names new CEO as top leader exits Hartford Business Journal

Achillion Pharma moves HQ to suburban Philly from New England; CEO says it’s easier to recruit here - Inquirer.com

Achillion Pharma moves HQ to suburban Philly from New England; CEO says it’s easier to recruit here Inquirer.com

Alexion inks deal to acquire Achillion for $930M upfront - Fierce Biotech

Alexion inks deal to acquire Achillion for $930M upfront Fierce Biotech

Achillion Pharmaceuticals Biotech Facility - Pharmaceutical Technology

Achillion Pharmaceuticals Biotech Facility Pharmaceutical Technology

Alexion dumps ex-Achillion C3G program after seeing phase 2 data - Fierce Biotech

Alexion dumps ex-Achillion C3G program after seeing phase 2 data Fierce Biotech

Achillion Reports Interim Results From ACH-3102 Phase 2a Trial - Quick Facts - RTTNews

Achillion Reports Interim Results From ACH-3102 Phase 2a Trial - Quick Facts RTTNews

Why Achillion Pharmaceuticals Stock Flew Higher Again Today - Yahoo Finance

Why Achillion Pharmaceuticals Stock Flew Higher Again Today Yahoo Finance

Alexion wraps up $930m acquisition of Achillion - Pharmaceutical Business review -

Alexion wraps up $930m acquisition of Achillion Pharmaceutical Business review -

Achillion Pharma Q4 Loss Narrows; Sees Wider-than- Expected Loss In FY08 - Update - RTTNews

Achillion Pharma Q4 Loss Narrows; Sees Wider-than- Expected Loss In FY08 - Update RTTNews

Drug stocks rise; Achillion rockets - MarketWatch

Drug stocks rise; Achillion rockets MarketWatch

Peter Kolchinsky, RA Capital Up Stake in Achillion Pharmaceuticals Even Higher - Insider Monkey

Peter Kolchinsky, RA Capital Up Stake in Achillion Pharmaceuticals Even Higher Insider Monkey

City blames building owners for Achillion blast - Prince George Citizen

City blames building owners for Achillion blast Prince George Citizen

Achillion owner ready to retire - Prince George Citizen

Achillion owner ready to retire Prince George Citizen

Dying Achilles! - enimerosi.com

Dying Achilles! enimerosi.com

Maria Callas Exhibition at Achillion Museum on Corfu - GTP Headlines

Maria Callas Exhibition at Achillion Museum on Corfu GTP Headlines

Angela Gerekou in Vienna to discuss collaboration between Achillion Palace and Schönbrunn Museum - enimerosi.com

Angela Gerekou in Vienna to discuss collaboration between Achillion Palace and Schönbrunn Museum enimerosi.com

“Three Ladies at the Opera” at Achillion Palace on Saturday 24 July - enimerosi.com

“Three Ladies at the Opera” at Achillion Palace on Saturday 24 July enimerosi.com

Maria Callas to ΄light up΄ Achillion Palace - enimerosi.com

Maria Callas to ΄light up΄ Achillion Palace enimerosi.com

Outdoor areas of Achillion Palace open to the public from 1 June - enimerosi.com

Outdoor areas of Achillion Palace open to the public from 1 June enimerosi.com

Top Achillion Pharmaceuticals, Inc. Employees

  • Laura Barrow

    Laura Barrow

    n/a

    Madison, Connecticut, United States, United States
    6
    alexion.com, comcast.net, synergypharma.com, pfizer.com, juno.com, achillion.com

    3 +186049XXXXX

  • Michael Elliot

    Michael Elliot

    n/a

    Stamford, Connecticut, United States, United States
    2
    yahoo.com, achillion.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant